Everolimus and Hormone Therapy in Treating Patients With Advanced Hormone Receptor Positive Breast Cancer That Has Progressed or Recurred on Everolimus and Exemestane Therapy

Conditions:   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast CancerInterventions:   Drug: everolimus;   Drug: anastrozole;   Drug: letrozole;   Drug: tamoxifen citrate;   Drug: fulvestrant;   Drug: megestrol acetateSponsors:   Emory University;   NovartisRecruiting - verified December 2014

Source: ClinicalTrials.gov - October 17, 2014 Category: Research Source Type: clinical trials